Repligen to buy BioLife in $1.5 billion deal to expand cell therapy business

Stocks Yahoo Finance By Yahoo Finance 22 Jul 2026 12:04 1 min read

Repligen to buy BioLife in $1.5 billion deal to expand cell therapy business

Repligen to buy BioLife in $1.5 billion deal to expand cell therapy business

Repligen to buy BioLife in $1.5 billion deal to expand cell therapy business

Read the full story on Yahoo Finance → Opens the original article on finance.yahoo.com

Summary aggregated from Yahoo Finance's public RSS feed. The full reporting belongs to Yahoo Finance — please read it on their site.